0001209191-16-137392.txt : 20160816
0001209191-16-137392.hdr.sgml : 20160816
20160816202324
ACCESSION NUMBER: 0001209191-16-137392
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160816
FILED AS OF DATE: 20160816
DATE AS OF CHANGE: 20160816
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Insys Therapeutics, Inc.
CENTRAL INDEX KEY: 0001516479
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 510327886
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10220 SOUTH 51ST STREET
STREET 2: SUITE 2
CITY: PHOENIX
STATE: AZ
ZIP: 85044
BUSINESS PHONE: 602-910-2617
MAIL ADDRESS:
STREET 1: 10220 SOUTH 51ST STREET
STREET 2: SUITE 2
CITY: PHOENIX
STATE: AZ
ZIP: 85044
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: STANLEY THEODORE H
CENTRAL INDEX KEY: 0000938296
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35902
FILM NUMBER: 161837331
MAIL ADDRESS:
STREET 1: 4745 WILEY POST WAY SUITE 650
STREET 2: C/O ANESTA CORP
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84116
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-08-16
0
0001516479
Insys Therapeutics, Inc.
INSY
0000938296
STANLEY THEODORE H
C/O INSYS THERAPEUTICS, INC.
444 SOUTH ELLIS STREET
CHANDLER
AZ
85224
1
0
0
0
Common Stock
2016-08-16
4
M
0
15000
5.96
A
17000
D
Common Stock
2016-08-16
4
S
0
15000
18.02
D
2000
D
Common Stock
6000
I
by non-profit corporation
Common Stock
10200
I
by limited partnership
Stock Option (right to buy)
5.96
2016-08-16
4
M
0
15000
0.00
D
2023-08-12
Common Stock
15000
15000
D
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.95 to $18.23 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The Reporting Person disclaims beneficial ownership of the Securities except to the extent of his pecuriniary interest therein.
The exercise price reflects a 3-for-2 forward stock split effected by the Issuer on March 28, 2014 and a 2-for-1 forward stock split effected by the Issuer on June 5, 2015.
One third of the shares subject to the option vested on August 12, 2014 and the remainder vested in 24 equal monthly installments thereafter until fully vested and exercisable on August 12, 2016.
On March 27, 2014 and June 5, 2015 the Issuer effected a 3-for-2 forward stock split and a 2-for-1 forward stock split, respectively, both pursuant to a stock dividend, resulting in the reporting person's ownership of an aggregate of 15,000 additional options.
/s/ Darryl S. Baker, Attorney-in-fact
2016-08-16